Ming (Darrick) Yao is a seasoned professional in biomarker and diagnostics within the realm of translational medicine, specializing in oncology. They have held significant positions, including China Biomarker & Dx Leader at Novartis and Head of Dx Strategy at Amgen since 2024. Ming has extensive experience in developing and implementing companion diagnostic strategies across multiple companies, including OrigiMed Inc. and Janssen Pharmaceutical. They earned a Doctor of Medicine in Immunology and an MBA from prestigious institutions, and they possess strong leadership and communication skills, fostering collaborations with academic and industry partners.
This person is not in the org chart
This person is not in any teams
This person is not in any offices